This inventor holds 1 USPTO granted patent and 8 published patent applications. Top assignee: Novartis Ag. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Francesca Orlandi: Innovator in Radiopharmaceuticals
Introduction
Francesca Orlandi is a notable inventor based in Ivrea, Italy. She has made significant contributions to the field of radiopharmaceuticals, particularly through her innovative patent that addresses the stability and concentration of radionuclide complex solutions.
Latest Patents
Francesca holds a patent for a "Stable, concentrated radiopharmaceutical composition." This invention relates to radionuclide complex solutions that are not only highly concentrated but also exhibit high chemical stability. The stability of the drug product is achieved through the use of at least one stabilizer that protects against radiolytic degradation. Notably, the introduction of two stabilizers during different stages of the manufacturing process has proven to be particularly advantageous.
Career Highlights
Francesca is currently employed at Novartis AG, a leading global healthcare company. Her work focuses on developing innovative solutions that enhance the efficacy and safety of radiopharmaceuticals. With her expertise, she has contributed to advancing medical diagnostics and therapeutic applications.
Collaborations
Francesca collaborates with esteemed colleagues, including Lorenza Fugazza and Maurizio F Mariani. Their combined efforts in research and development have fostered a collaborative environment that drives innovation in their field.
Conclusion
Francesca Orlandi's work in the realm of radiopharmaceuticals exemplifies the impact of innovation in healthcare. Her patent for a stable and concentrated radiopharmaceutical composition highlights her commitment to improving medical treatments. Through her career at Novartis AG and her collaborations, she continues to pave the way for advancements in this critical area of medicine.